Johnson & Johnson Q4 2024 Earnings Report
Key Takeaways
Johnson & Johnson reported a 5.3% increase in Q4 sales, reaching $22.5 billion. EPS was reported at $1.41 and adjusted EPS at $2.04, which included $(0.22) impact from acquired IPR&D charges related to the V-Wave acquisition. The company issued guidance for 2025, projecting operational sales growth of 2.5% - 3.5% and adjusted operational EPS of $10.75 - $10.95.
Q4 2024 sales increased by 5.3% to $22.5 billion with operational growth of 6.7%.
Q4 2024 EPS was $1.41, and adjusted EPS was $2.04, including a $(0.22) impact from acquired IPR&D charges.
Full-year sales grew by 4.3% to $88.8 billion, with operational growth of 5.9%.
The company is guiding for 2025 with operational sales growth of 2.5% - 3.5% and adjusted operational EPS of $10.75 - $10.95.
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson Revenue by Segment
Forward Guidance
Johnson & Johnson issued guidance for 2025, expecting adjusted operational sales growth and adjusted EPS (diluted).
Positive Outlook
- Adjusted Operational Sales growth of 2.0% – 3.0%
- Operational Sales growth of 2.5% – 3.5%
- Estimated Reported Sales growth of 0.5% – 1.5%
- Adjusted Operational EPS (Diluted) growth of 7.7% – 9.7%
- Adjusted EPS (Diluted) growth of 5.2% – 7.2%